Stella Diagnostics Inc.
SLDX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $252 | $598 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,015 | $11,427 | $2,198 | $4,142 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,015 | $11,427 | $2,450 | $4,740 |
| Operating Income | -$1,015 | -$11,427 | -$2,450 | -$4,740 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$221 | $5,720 | -$3,191 | -$11,901 |
| Pre-Tax Income | -$1,236 | -$5,707 | -$5,641 | -$16,641 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,236 | -$5,707 | -$5,641 | -$16,641 |
| % Margin | – | – | – | – |
| EPS | -0.003 | -0.019 | -0.034 | -0.17 |
| % Growth | 83.7% | 44.4% | 79.9% | – |
| EPS Diluted | -0.003 | -0.019 | -0.034 | -0.17 |
| Weighted Avg Shares Out | 401,600 | 299,991 | 165,119 | 96,365 |
| Weighted Avg Shares Out Dil | 401,600 | 299,991 | 165,119 | 96,365 |
| Supplemental Information | – | – | – | – |
| Interest Income | $30 | $154 | $0 | $0 |
| Interest Expense | $0 | $0 | $311 | $304 |
| Depreciation & Amortization | $0 | $168 | $228 | $237 |
| EBITDA | -$1,236 | -$5,540 | -$5,101 | -$16,100 |
| % Margin | – | – | – | – |